From Calvin to the Cutting-Edge of Drug Development
July 31, 2026
July 31, 2026
GRAND RAPIDS, Michigan, July 31 -- Calvin University posted the following news:
* * *
From Calvin to the Cutting-Edge of Drug Development
*
Kyle Timmer '20 spends his days helping turn cutting-edge drug discoveries into treatments that can reach patients. As a senior scientist for AbbVie, a pharmaceutical company based in Chicago, his role sits at the intersection of R&D (research and development) and commercial-scale manufacturing.
* * *
From Calvin to the Cutting-Edge of Drug Development
*
Kyle Timmer '20 spends his days helping turn cutting-edge drug discoveries into treatments that can reach patients. As a senior scientist for AbbVie, a pharmaceutical company based in Chicago, his role sits at the intersection of R&D (research and development) and commercial-scale manufacturing.
